ANTIBIOTICE
84 articole · RSS
Antibiotice Iasi Export Revenue Doubles In H1 2024 Vs H1 2020
Antibiotice Iasi (ATB.RO), the largest Romanian-held drug producer, posted RON150 million revenue from exports in the first half of 2024, an increase of 25% on the year-ago period.
Romanian-Held Pharmaceutical Manufacturer Antibiotice To Get EUR100M In EU Funding To Make Critical Drugs
Antibiotice Iasi, (ATB.RO) the largest Romanian-owned pharmaceutical producer, will receive EUR100 million in EU funding for the production of drugs such as antibiotics, for which there are...
First Loan Via InvestEU In Romania Goes To Antibiotice Iasi For New Plant
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) has signed a EUR25 million loan agreement with the European Investment Bank (EIB), which will help finance the construction of new produ...
Antibiotice Iasi Ends First Half With 83% Rise In Profit
Antibiotice Iasi (ATB.RO), the most important Romanian producer of generic drugs, recorded sales of RON315.9 million in the first half of 2023, a 27% increase compared with the first half of...
Antibiotice Iasi Gets RON4.1M Funding For Photovoltaic Park
Antibiotice Iasi (ATB.RO), Romania’s largest producer of generic drugs, on Wednesday notified the Bucharest Stock Exchange of having received RON4.08 million from the Ministry of European In...
Antibiotice Iasi Gets RON85M State Aid For Production And Logistics Facility
Romania’s most important generic drug manufacturer Antibiotice Iasi (ATB.RO) has received from the Romanian government the approval for the funding of a project for manufacturing, packaging...
Antibiotice Aims to Invest RON88M in 2023
Romanian pharmaceutical producer Antibiotice wants to invest over RON88 million in 2023 in the Iasi production platform, from own resources and reserves, in line with its budget.
Antibiotice Iasi Sales up 54% to RON248M in H1
Romanian pharmaceutical manufacturer Antibiotice (ATB.RO) Iasi’s total revenue from sales reached RON248.1 million in the first half of 2022, up 54% on the RON161.4 million in the year-ago p...
Antibiotice Wants to Develop Two Plants at Its Iasi Site
Drug manufacturer Antibiotice Iasi (ATB.RO) wants to build two new factories for sterile products and sterile topical products, a total investment of RON200 million.